TrialTargeted oncology2019

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520.

Remy B Verheijen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.